Chemotherapy News and Research

Latest Chemotherapy News and Research

Machine-learning approach could accurately predict the evolution of breast cancer

Machine-learning approach could accurately predict the evolution of breast cancer

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

Tips of cancer survivors' tongues are less sensitive to tastes, study finds

Tips of cancer survivors' tongues are less sensitive to tastes, study finds

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

Natural compound myricetin shows antiviral potential against SARS-CoV-2

Natural compound myricetin shows antiviral potential against SARS-CoV-2

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Protein blueprint may aid in treatments for infertility and help protect future fertility

Protein blueprint may aid in treatments for infertility and help protect future fertility

CU Cancer Center researcher investigates new treatment sequence for esophageal cancer

CU Cancer Center researcher investigates new treatment sequence for esophageal cancer

Researchers develop new therapeutic approach for treating acute myeloid leukemia

Researchers develop new therapeutic approach for treating acute myeloid leukemia

New breakthrough could lead to a cure for common childhood cancer

New breakthrough could lead to a cure for common childhood cancer

Understanding the risks and benefits of cannabis use among young patients

Understanding the risks and benefits of cannabis use among young patients

‘It’s a mission’: Volunteers treat refugees massing at the border

‘It’s a mission’: Volunteers treat refugees massing at the border

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Adding immune oncology drug to chemotherapy improves response in subset of breast cancer patients

Adding immune oncology drug to chemotherapy improves response in subset of breast cancer patients

Improved treatment and better prognosis for testicular cancer patients

Improved treatment and better prognosis for testicular cancer patients

Global blood centers join hands to develop more efficient, accurate blood typing technology

Global blood centers join hands to develop more efficient, accurate blood typing technology

Different comorbid conditions in COVID-19 patients can impact outcomes of positive PCR test results

Different comorbid conditions in COVID-19 patients can impact outcomes of positive PCR test results

Using natural killers from the immune system to target breast cancer cells

Using natural killers from the immune system to target breast cancer cells

P-glycoprotein shows ability to remove a toxin associated with Alzheimer's from the brain

P-glycoprotein shows ability to remove a toxin associated with Alzheimer's from the brain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.